These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 17580596

  • 1. Long-term nightly treatment with indiplon in adults with primary insomnia: results of a double-blind, placebo-controlled, 3-month study.
    Scharf MB, Black J, Hull S, Landin R, Farber R.
    Sleep; 2007 Jun; 30(6):743-52. PubMed ID: 17580596
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
    Lydiard RB, Lankford DA, Seiden DJ, Landin R, Farber R, Walsh JK.
    J Clin Sleep Med; 2006 Jul 15; 2(3):309-15. PubMed ID: 17561543
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of indiplon in older adults with primary insomnia.
    Walsh JK, Moscovitch A, Burke J, Farber R, Roth T.
    Sleep Med; 2007 Nov 15; 8(7-8):753-9. PubMed ID: 17825616
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of as-needed, post bedtime dosing with indiplon in insomnia patients with chronic difficulty maintaining sleep.
    Roth T, Zammit GK, Scharf MB, Farber R.
    Sleep; 2007 Dec 15; 30(12):1731-8. PubMed ID: 18246982
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of indiplon in transient insomnia.
    Rosenberg R, Roth T, Scharf MB, Lankford DA, Farber R.
    J Clin Sleep Med; 2007 Jun 15; 3(4):374-9. PubMed ID: 17694726
    [Abstract] [Full Text] [Related]

  • 6. Indiplon: a nonbenzodiazepine sedative-hypnotic for the treatment of insomnia.
    Marrs JC.
    Ann Pharmacother; 2008 Jul 15; 42(7):1070-9. PubMed ID: 18594049
    [Abstract] [Full Text] [Related]

  • 7. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.
    Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, Roth T.
    Sleep; 2003 Nov 01; 26(7):793-9. PubMed ID: 14655910
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.
    Krystal AD, Durrence HH, Scharf M, Jochelson P, Rogowski R, Ludington E, Roth T.
    Sleep; 2010 Nov 01; 33(11):1553-61. PubMed ID: 21102997
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia.
    Lankford A, Rogowski R, Essink B, Ludington E, Heith Durrence H, Roth T.
    Sleep Med; 2012 Feb 01; 13(2):133-8. PubMed ID: 22197474
    [Abstract] [Full Text] [Related]

  • 10. Effect of gaboxadol on sleep in adult and elderly patients with primary insomnia: results from two randomized, placebo-controlled, 30-night polysomnography studies.
    Lankford DA, Corser BC, Zheng YP, Li Z, Snavely DB, Lines CR, Deacon S.
    Sleep; 2008 Oct 01; 31(10):1359-70. PubMed ID: 18853933
    [Abstract] [Full Text] [Related]

  • 11. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
    Ancoli-Israel S, Krystal AD, McCall WV, Schaefer K, Wilson A, Claus R, Rubens R, Roth T.
    Sleep; 2010 Feb 01; 33(2):225-34. PubMed ID: 20175406
    [Abstract] [Full Text] [Related]

  • 12. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
    Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T, ZOLONG Study Group.
    Sleep; 2008 Jan 01; 31(1):79-90. PubMed ID: 18220081
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug 01; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 14. Indiplon: the development of a novel therapy for the treatment of sleep onset and sleep maintenance insomnia.
    Lankford A, Ancoli-Israel S.
    Int J Clin Pract; 2007 Jun 01; 61(6):1037-45. PubMed ID: 17386060
    [Abstract] [Full Text] [Related]

  • 15. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.
    Walsh JK, Krystal AD, Amato DA, Rubens R, Caron J, Wessel TC, Schaefer K, Roach J, Wallenstein G, Roth T.
    Sleep; 2007 Aug 01; 30(8):959-68. PubMed ID: 17702264
    [Abstract] [Full Text] [Related]

  • 16. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
    Walsh JK, Salkeld L, Knowles LJ, Tasker T, Hunneyball IM.
    Sleep Med; 2010 Jan 01; 11(1):23-30. PubMed ID: 19945340
    [Abstract] [Full Text] [Related]

  • 17. A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia.
    Scharf M, Erman M, Rosenberg R, Seiden D, McCall WV, Amato D, Wessel TC.
    Sleep; 2005 Jun 01; 28(6):720-7. PubMed ID: 16477959
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia.
    Krystal AD, Lankford A, Durrence HH, Ludington E, Jochelson P, Rogowski R, Roth T.
    Sleep; 2011 Oct 01; 34(10):1433-42. PubMed ID: 21966075
    [Abstract] [Full Text] [Related]

  • 19. A polysomnography study of eszopiclone in elderly patients with insomnia.
    McCall WV, Erman M, Krystal AD, Rosenberg R, Scharf M, Zammit GK, Wessel T.
    Curr Med Res Opin; 2006 Sep 01; 22(9):1633-42. PubMed ID: 16968566
    [Abstract] [Full Text] [Related]

  • 20. Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem.
    Roehrs TA, Roth T.
    J Clin Sleep Med; 2016 Mar 01; 12(3):319-25. PubMed ID: 26446253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.